Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celestica (CLS) Cash & Equivalents (2016 - 2025)

Celestica (CLS) has disclosed Cash & Equivalents for 10 consecutive years, with $595.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 40.7% to $595.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $595.6 million, a 40.7% increase, with the full-year FY2025 number at $595.6 million, up 40.7% from a year prior.
  • Cash & Equivalents was $595.6 million for Q4 2025 at Celestica, up from $305.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $595.6 million in Q4 2025 to a low of $3.6 million in Q4 2023.
  • A 5-year average of $339.2 million and a median of $344.2 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 99.04% in 2023, then skyrocketed 11658.33% in 2024.
  • Celestica's Cash & Equivalents stood at $394.0 million in 2021, then dropped by 4.95% to $374.5 million in 2022, then crashed by 99.04% to $3.6 million in 2023, then surged by 11658.33% to $423.3 million in 2024, then skyrocketed by 40.7% to $595.6 million in 2025.
  • Per Business Quant, the three most recent readings for CLS's Cash & Equivalents are $595.6 million (Q4 2025), $305.9 million (Q3 2025), and $313.8 million (Q2 2025).